A detailed history of Ehp Funds Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Ehp Funds Inc. holds 209,385 shares of STIM stock, worth $412,488. This represents 0.77% of its overall portfolio holdings.

Number of Shares
209,385
Holding current value
$412,488
% of portfolio
0.77%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$2.63 - $4.66 $550,682 - $975,734
209,385 New
209,385 $550,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $53.2M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Ehp Funds Inc. Portfolio

Follow Ehp Funds Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ehp Funds Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ehp Funds Inc. with notifications on news.